Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Scherle

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1988
Differential ability of B cells specific for external vs. internal influenza virus proteins to respond to help from influenza virus-specific T-cell clones in vivoP A Scherle, W Gerhard
The Journal of Experimental Medicine|October 1, 1986
Functional analysis of influenza-specific helper T cell clones in vivo. T cells specific for internal viral proteins provide cognate help for B cell responses to hemagglutininP A Scherle, W Gerhard
Current Topics in Microbiology and Immunology|January 1, 1990
Functionality of clonal lymphoid progenitor cells expressing the P210 BCR/ABL oncogeneP A Scherle, O N Witte
Journal of Virology|November 1, 1991
Activity of CD4+ T-cell clones of type 1 and type 2 in generation of influenza virus-specific cytotoxic responses in vitroG Palladino, P A Scherle, W Gerhard
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1992
Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cellsP A Scherle, G Palladino, W Gerhard
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1990
Clonal lymphoid progenitor cell lines expressing the BCR/ABL oncogene retain full differentiative functionP A Scherle, K Dorshkind, O N Witte
Cell Proliferation|September 9, 2009
ADAM-mediated amphiregulin shedding and EGFR transactivationS Kasina, P A Scherle, C L Hall, et al.
Current Cancer Drug Targets|December 23, 2009
Indoleamine 2,3-dioxygenase, an emerging target for anti-cancer therapyX Liu, R C Newton, S M Friedman, et al.
Biochemistry|June 24, 1998
Competitive inhibition of MAP kinase activation by a peptide representing the alpha C helix of ERKK Y Horiuchi, P A Scherle, J M Trzaskos, et al.
The Journal of Experimental Medicine|May 1, 1996
Anergic T cells are defective in both jun NH2-terminal kinase and mitogen-activated protein kinase signaling pathwaysD R DeSilva, W S Feeser, E J Tancula, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1988
Differential ability of B cells specific for external vs. internal influenza virus proteins to respond to help from influenza virus-specific T-cell clones in vivoP A Scherle, W Gerhard
The Journal of Experimental Medicine|October 1, 1986
Functional analysis of influenza-specific helper T cell clones in vivo. T cells specific for internal viral proteins provide cognate help for B cell responses to hemagglutininP A Scherle, W Gerhard
Current Topics in Microbiology and Immunology|January 1, 1990
Functionality of clonal lymphoid progenitor cells expressing the P210 BCR/ABL oncogeneP A Scherle, O N Witte
Journal of Virology|November 1, 1991
Activity of CD4+ T-cell clones of type 1 and type 2 in generation of influenza virus-specific cytotoxic responses in vitroG Palladino, P A Scherle, W Gerhard
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1992
Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cellsP A Scherle, G Palladino, W Gerhard
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1990
Clonal lymphoid progenitor cell lines expressing the BCR/ABL oncogene retain full differentiative functionP A Scherle, K Dorshkind, O N Witte
Cell Proliferation|September 9, 2009
ADAM-mediated amphiregulin shedding and EGFR transactivationS Kasina, P A Scherle, C L Hall, et al.
Current Cancer Drug Targets|December 23, 2009
Indoleamine 2,3-dioxygenase, an emerging target for anti-cancer therapyX Liu, R C Newton, S M Friedman, et al.
Biochemistry|June 24, 1998
Competitive inhibition of MAP kinase activation by a peptide representing the alpha C helix of ERKK Y Horiuchi, P A Scherle, J M Trzaskos, et al.
The Journal of Experimental Medicine|May 1, 1996
Anergic T cells are defective in both jun NH2-terminal kinase and mitogen-activated protein kinase signaling pathwaysD R DeSilva, W S Feeser, E J Tancula, et al.
Pageof 3